It’s only a small-scale project, but it’s exciting to see new funding models being tried out for drug development.
Here on Techdirt we’ve been pretty scathing about the way that Big Pharma develops drugs — often poorly — and then uses patent monopolies to keep prices so high that only rich Westerners can afford them. Of course, it’s easy to complain about the flaws of the current approach, but are there any alternatives? We’ve already covered one — using prizes – and now Carl Levinson points us to another potentially powerful approach: crowdsourcing. It’s already been adopted by ‘Project Marilyn’ to develop a patent-free anti-cancer drug:
The campaign will fund a xenograft experiment, which is the next step in developing the promising anti-cancer compound “9DS”. This experiment needs to be completed before 9DS can move on to clinical trials.
Here are some more details of both the drug and the project:
The drug candidate 9DS was developed at the University of Maryland. The last work done on the drug showed that it had activity against cancer competitive with leading cancer drugs such as taxol. Moreover, 9DS is also likely to have lower side effects than most chemotherapies, since a related compound, SJG-136, seems to have low side effects in early clinical trials.
Project Marilyn involves: production of more 9DS, and submitting 9DS to a xenograft study (‘curing cancer in mice’). This is the next step in drug development and an important one on the way to doing clinical (human) studies. The process we’re seeking to fund should take approximately 6 months. If we receive more funding, we will add stretch goals, such as further preclinical experiments on 9DS, development 9DS analogs, or other exciting anti-cancer ideas.
Of course, even if enough money is raised — at the time of writing, just over a quarter of the crowdfunding target has been pledged — there’s still much more work to be done before the drug can be sold to the public. An article in the Times of San Diego explains what will happen next:
The Latest on: Patent-free drug
via Google News
The Latest on: Patent-free drug
- DGAP-News: Dermapharm Holding SE increases free floaton July 1, 2019 at 8:08 am
Grünwald, July 1, 2019 - Dermapharm Holding SE ("Dermapharm"), a leading manufacturer of patent-free branded drugs for selected therapeutic areas in Germany with a growing international presence, has ... […]
- DGAP-News: Dermapharm Holding SE increases free floaton July 1, 2019 at 8:00 am
Grünwald, July 1, 2019 - Dermapharm Holding SE ("Dermapharm"), a leading manufacturer of patent-free branded drugs for selected therapeutic areas in Germany with a growing international presence ... […]
- Diabetes: Livesaving Insulin Is Cripplingly Expensive—but DIY Drug Makers Could Be About to Change That | Opinionon September 14, 2018 at 6:44 am
Patents help drug companies recoup the costs from their investments ... The goal of the Open Insulin Project is to figure out a patent-free method and release the information, so that competing ... […]
- FDA's New Generic EpiPen Approval Exemplifies Progress on Drug Price Reformon August 23, 2018 at 5:49 am
The problem of unaffordable drug prices is restricted to two areas ... Suffice it to say that epinephrine is patent-free. But Mylan has patented the particular type of injector used to administer the ... […]
- A law professor’s big idea for combatting greedy drug company titans like Martin Shkrelion September 21, 2017 at 6:20 am
In 2015, CEO of Turing Pharmaceuticals Martin Shkreli infamously raised the price of the life-saving drug Daraprim by 5,000% ... Expanding grants for patent-free, open-source research would focus ... […]
- Escaping Big Pharma’s Pricing With Patent-Free Drugson July 18, 2017 at 12:55 am
How’s this for a great deal? The United States government funded research and development of a new vaccine against Zika. But the Army, which paid a French pharmaceutical manufacturer for its ... […]
- This Scientist Is Using Open Sourced Software Techniques To Turn Bugs Into Patent-Free Drugson October 25, 2014 at 5:00 pm
Chemist and “semi-recreational” codemonkey Isaac Yonemoto is running a crowdfunding campaign called Project Marilyn to create open sourced, patent-free cancer drugs. Yonemoto proposes a $75,000 ... […]
- Crowdfunding Cancer Research? The Drug Awaits Testingon September 29, 2014 at 11:56 am
Project Marilyn is looking to crowdfund a patent-free anti-cancer drug. We've seen crowdfunding jump the shark when Zack Danger Brown raised over $50,000 to make potato salad; now, one group is ... […]
- San Diego Researcher Crowdfunding Patent-Free Cancer Drugon September 20, 2014 at 8:12 pm
Dr. Isaac Yonemoto founded IndySci as a crowdfunding platform for Project Marilyn— a campaign that seeks to develop a patent-free cancer drug based on an open-source ideology. “When software ... […]
- Analysis: Open-access R&D one answer to drug industry woeson September 28, 2011 at 9:15 am
Stephen Friend — another founder of the patent-free drug development project known as Arch2POCM — is also an industry veteran, having founded Rosetta Inpharmatics and gone on to head Merck & Co’s ... […]
via Bing News